Copeptin as a Biomarker of Atherosclerosis in Type 1 Diabetic Patients

AIM: To evaluate copeptin as an early marker of atherosclerosis in adolescent type 1 diabetics. METHODS: Sixty-two type 1 diabetic patients and 50 healthy volunteers were enrolled in the study. Serum copeptin, glycosylated haemoglobin (HbA1c), lipid profile, oxidised low-density lipoprotein (OxLDL),...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Open Access Maced J Med Sci
Prif Awduron: El Dayem, Soha M. Abd, Battah, Ahmed A., El Bohy, Abo El Magd, Yousef, Rasha Nazih, Talaat, Ahmed
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Republic of Macedonia 2020
Pynciau:
Clinical Sciences
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061391/
https://ncbi.nlm.nih.gov/pubmed/33318769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3889/oamjms.2019.643
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg